Lifeward (LFWD) Long-Term Debt Issuances (2016 - 2026)
Lifeward recorded quarterly Long-Term Debt Issuances of $1.0 million in Q1 2026, down 87.19% quarter-over-quarter from $8.0 million in Q4 2016.
Lifeward's Long-Term Debt Issuances history runs 2 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Long-Term Debt Issuances changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (changed N/A YoY), while the FY2025 annual figure was $1.4 million, changed N/A from the prior year.
- Long-Term Debt Issuances came in at $1.0 million for Q1 2026 at Lifeward, down from $8.0 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $1.0 million in Q1 2026 to a low of $1.0 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.71 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2016 | 8.00 Mn |
| Dec 31, 2016 | 8.00 Mn |
| Mar 31, 2016 | 12.00 Mn |
| Mar 31, 2016 | 12.00 Mn |